A recent study reveals that people who stop using new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who end conventional lifestyle plans.
Published data in a prominent health publication points out that while overweight individuals frequently drop about a fifth of their body weight while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.
"Individuals using such treatments need to be informed of the danger of quick weight regain when the medication ends," warns lead investigator Dr. Susan Jebb.
That rate of recovery means a reversion to original weight within about a year and a half.
Analyzing Approaches
The study, which reviewed dozens of studies involving over 9,000 of patients, compared the results of GLP-1 agonists with conventional dieting.
Scientists note that individuals who shed pounds through lifestyle changes alone usually experience a slower creep back—around 0.1 kg a month—once they finish.
Explaining the Rapid Rebound
Nutrition scientists propose the way of the injections accounts for the amplified rebound.
GLP-1 drugs copy a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of the hormone levels far above than normal may cause the system to produce less of its endogenous GLP-1, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication results in appetite is uncontrolled, making overeating a significant risk."
A Chronic Condition?
Medical guidelines suggest the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Many experts say that, due to the high risk of relapse, the therapy is often long-term.
This perspective is supported by pharmaceutical companies, who note that the results "emphasize the chronic nature of obesity," akin to managing conditions like hypertension.
User Testimonies
Individuals who have stopped the medication describe a sudden resurgence of cravings.
"I experienced a trigger that goes on and you're instantly starving," recalled a patient.
This difficulty is worsened if users have not adopted lasting lifestyle or habit modifications during therapy.
Significant Interest
Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest being substantial.
- Use is more common among women than men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the medications through private healthcare rather than public health services.
In conclusion, clinicians caution that while the jabs are effective tools for shedding pounds, they are not a magic fix and maintained weight loss relies on combined lifestyle changes.
